Demcizumab Uses, Dosage, Side Effects and more
Demcizumab is under investigation for the treatment of Nonsquamous Nonsmall Cell Neoplasm of Lung.
| Trade Name | Demcizumab |
| Generic | Demcizumab |
| Demcizumab Other Names | Demcizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
